Drug
lutetium lu 177 vipivotide tetraxetan
Marketed as PLUVICTO.
Generic name
lutetium lu 177 vipivotide tetraxetan
Brand names
PLUVICTO
First FDA approval
2022-03-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215833 | PLUVICTO | 2022-03-23 | NOVARTIS |
Manufacturers
NOVARTIS
Frequently asked questions
When was lutetium lu 177 vipivotide tetraxetan FDA approved?
Earliest FDA approval on record: 2022-03-23.
What brand names are sold as lutetium lu 177 vipivotide tetraxetan?
PLUVICTO.
Sources
Appeal a lutetium lu 177 vipivotide tetraxetan denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com